Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What modifications does aurobindo make to clonazepam?

See the DrugPatentWatch profile for clonazepam

What Is Aurobindo's Clonazepam?

Aurobindo Pharma manufactures generic clonazepam tablets in strengths of 0.5 mg, 1 mg, and 2 mg, approved by the FDA as bioequivalent to Roche's Klonopin.[1] These are immediate-release oral tablets used for seizure disorders and panic disorder.

Key Formulation Modifications from Brand Klonopin

Aurobindo's version uses the same active ingredient, clonazepam, at identical strengths. Inactive ingredients differ slightly for manufacturing and stability:
- Excipients: Includes lactose monohydrate, microcrystalline cellulose, pregelatinized starch, sodium starch glycolate, magnesium stearate (in core tablet).
- Coating: Hypromellose, talc, polyethylene glycol, titanium dioxide, plus colorants like FD&C Blue #2 (0.5 mg), FD&C Red #40 (1 mg), or iron oxide yellow/D&C Yellow #10 (2 mg).[2]

These changes ensure equivalence under FDA standards (AB rating), with no impact on absorption, efficacy, or safety. Lactose content is low (~50-100 mg/tablet), but patients with lactose intolerance should check labels.

Why These Changes?

Generic makers like Aurobindo adjust excipients to use cost-effective, widely available materials while meeting bioequivalence criteria (90% confidence interval of 80-125% AUC and Cmax vs. brand).[3] No proprietary modifications like extended-release; it's a standard IR tablet.

Patent and Approval Timeline

Aurobindo's ANDA (207201) was approved October 24, 2014.[1] Clonazepam patents expired long ago (original 1975; key patents ~1990s), enabling generics. No active Orange Book patents block Aurobindo's version.[4]

Patient-Reported Differences

Some users note minor cosmetic variances (e.g., shape: Aurobindo's are round, scored; Klonopin oval) or perceived taste from coating. FDA data shows no therapeutic differences; switchbacks are rare (0.1-0.5% rate).[5] Allergic reactions to dyes or lactose possible—consult pharmacist.

Competitors' Versions

| Manufacturer | Strengths | Notable Excipient Diff | FDA Approval |
|--------------|-----------|-------------------------|--------------|
| Aurobindo | 0.5,1,2 mg | Lactose-based | 2014[1] |
| Accord | 0.5,1,2 mg | Corn starch, no lactose| 2011 |
| Mylan (Viatris) | 0.5,1,2 mg | Anhydrous lactose | 1998 |
| Teva | 0.5,1,2 mg | Mannitol (lactose-free)| 2006[2] |

Choose based on allergies; all AB-rated.

[1]: FDA Orange Book - Clonazepam
[2]: DailyMed - Aurobindo Clonazepam
[3]: FDA Bioequivalence Guidance
[4]: DrugPatentWatch - Clonazepam
[5]: FDA Generic Approvals Database



Other Questions About Clonazepam :

Is Clonazepam a long-acting benzodiazepine? What storage precautions do aurobindo employees learn for clonazepam? What ppe is generally recommended when handling clonazepam at aurobindo? What employee training does aurobindo provide for clonazepam production? How does aurobindo's clonazepam production affect its therapeutic effectiveness? How long until clonazepam alleviates anxiety symptoms? What lab tests verify clonazepam purity at aurobindo?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy